Epidemiology and Intervention of Obstructive Sleep Apnea Based on Community

Sponsor
Guangdong Provincial People's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03280914
Collaborator
(none)
103
1
29
3.6

Study Details

Study Description

Brief Summary

This observational study in a real-world community was designed to perform epidemiological investigation and assess effect of CPAP intervention of obstructive sleep apnea.

Detailed Description

Patients with obstructive sleep apnea receiving CPAP or not would be observed in years. Primarily Impact of CPAP on health assessment andx control rate of hypertension would evaluated.

Study Design

Study Type:
Observational
Actual Enrollment :
103 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Epidemiology and Intervention of Obstructive Sleep Apnea Based on Community: a Real World Study
Actual Study Start Date :
Aug 1, 2017
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
CPAP group

Automatic Continuous Positive Airway Pressure treatment and usual care

Device: Auto-CPAP
Automatic Continuous Positive Airway Pressure treatment is the first-line treatment of obstructive sleep apnea

Usual care group

Usual care without Continuous Positive Airway Pressure treatment

Outcome Measures

Primary Outcome Measures

  1. Health assessment [From 1st Aug 2017 to 31st Dec 2020]

    Health assessment would be performed by 36-Item Short-Form Health Survey.

  2. Sleep quality [From 1st Aug 2017 to 31st Dec 2020]

    Sleep quality would be performed by Pittsburgh Sleep Quality Index.

  3. Psychological assessment [From 1st Aug 2017 to 31st Dec 2020]

    Psychological assessment would be performed by Hospital Anxiety and Depression Scale.

  4. Control rate of hypertension [From 1st Aug 2017 to 31st Dec 2020]

Secondary Outcome Measures

  1. Incidence of chronic diseases [From 1st Aug 2017 to 31st Dec 2025]

    Chronic diseases include hypertension, coronary heart disease, stroke and diabetes.

  2. Death from all-cause [From 1st Aug 2017 to 31st Dec 2025]

  3. Medical cost [From 1st Aug 2017 to 31st Dec 2025]

    Medical fee, annually time of outpatient visit and hospitalization

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. AHI >= 5 events/h
Exclusion Criteria:
  1. Any condition which in the opinion of researched makes the eligible participants unsuitable for this study, such as severe COPD, heart failure in NYHA class III to IV, and others

  2. Any condition potentially precluding follow-up visits, such as sereve insomnia, cognitive behavioral disorder, and others

  3. Patients receiving CPAP treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Community of Huanghua Road Guangzhou China 510000

Sponsors and Collaborators

  • Guangdong Provincial People's Hospital

Investigators

  • Principal Investigator: Qiong Ou, M.D., Guangdong Provincial People's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Guangdong Provincial People's Hospital
ClinicalTrials.gov Identifier:
NCT03280914
Other Study ID Numbers:
  • GDREC2016275H(R1)
First Posted:
Sep 13, 2017
Last Update Posted:
Feb 6, 2020
Last Verified:
Jun 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Guangdong Provincial People's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 6, 2020